StonvexLoading…
StonvexStonvexStonvexCore line items from TRNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q4 2025 2025-12-27 | Q3 2025 2025-09-30 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $242.55M | $158.70M | $158.70M | $76.42M |
Operating Income | $8.93M | Not available | $8.84M | $5.34M |
Net Income | $3.43M | Not available | $1.27M | $3.26M |
EPS (Diluted) | $0.37 | Not available | $0.48 | $0.35 |
Total Assets | $472.89M | Not available | $484.89M | $392.54M |
Total Liabilities | $176.12M | Not available | $189.47M | $100.00M |
Cash & Equivalents | $3.47M | Not available | $5.08M | $1.86M |
Free Cash Flow OCF − CapEx | $16.94M | Not available | $7.47M | $-975.00K |
Shares Outstanding | 9.33M | Not available | 9.33M | 9.32M |